Abstract: A non-invasive method of testing for inflammatory bowel disease using a domain specific monoclonal antibody is described. A unique 18 residue amino acid sequence overexpressed in COX-2 has been identified for making and using the monoclonal antibody.
Abstract: The provides compounds for the treatment of sickle-cell disease. In particular, the invention provides 5-membered heterocyclic anti-sickling agents that are highly effective and non-toxic, and methods for their use. The compounds include analogues and derivatives of naturally occurring occurring 5-hydroxymethyl-2-furfuraldehyde, 5-Ethyl-2-furfuraldehyde, 5-Methyl-2-furfuraldehyde, and 2-furfuraldehyde, and prodrug forms of the compound.
Type:
Grant
Filed:
December 3, 2003
Date of Patent:
January 9, 2007
Assignee:
Xechem International, Inc.
Inventors:
Martin K. Safo, Richmond Danso-Danquah, Samuel Nokuri, Faik N. Musayev, Gajanan S. Joshi, James C. Burnett, Donald J. Abraham
Abstract: A unique writing instrument. Preferred is an open-ended barrel in a wishbone configuration. A method of producing the writing instrument is also described.
Abstract: A method for isolating viable, biologically substantially pure exfoliated fecal colonocytes at normal ambient temperature is described. Immunocoprocytes and inflammatory cells indicative of certain gastrointestinal conditions and a noninvasive method for detecting colorectal cancer are set forth. Composition of transport and suspension media for isolation of colonocytes are detailed.
Abstract: The invention discloses an isolated, biologically pure culture of a microorganism, Bacillus licheniformis, strain SB3086 for use as an environmentally desirable biofungicide. The invention also discloses a method for enhancing biofungicidal activity of a microbial agent. The inventional further discloses a nutrient composition comprising a microbial agent and a method for controlling plant fungal diseases and infestation of Aspergillis niger utilizing, said strain.
Abstract: The invention discloses a Gram-positive microorganism, Bacillus megaterium that effectively and efficiently degrades fats, oils and grease. A composition comprising said microorganism and a method for degrading fatty acids and grease are also disclosed. Availability of glycerol to the biodegrading microorganism was discovered to enhance biodegradation.
Type:
Grant
Filed:
April 23, 2002
Date of Patent:
November 16, 2004
Assignee:
Novozymes Biologicals, Inc.
Inventors:
Jessi Lind Tisinger, Domenic A. Paone, Jonathan Leder, David J. Drahos
Abstract: A unique writing instrument. Preferred is a bow shaped barrel with an arched and hinged or flexible upper member and a rigid lower member. A method of producing the writing instrument is also described.
Abstract: A comfortable grip attachment to an article. Preferred is a bristle grip in various shapes and sizes. A method of producing the grip is also described.
Abstract: The invention discloses a Gram-positive microorganism, Bacillus megaterium, that effectively and efficiently degrades fats, oils and grease. A composition comprising said microorganism and a method for degrading fatty acids and grease are also disclosed.
Type:
Grant
Filed:
May 18, 2001
Date of Patent:
November 18, 2003
Inventors:
Jessi Lind Tisinger, David Joseph Drahos, Jonathan Leder, Domenic Anthony Paone
Abstract: A method for isolating viable, biologically substantially pure exfoliated fecal colonocytes at normal ambient temperature is described. Immunocoprocytes and inflammatory cells indicative of certain gastrointestinal conditions and a noninvasive method for detecting colorectal cancer are set forth. Composition of transport and suspension media for isolation of colonocytes are detailed.
Abstract: A method for isolating viable, biologically substantially pure exfoliated fecal colonocytes at normal ambient temperature is described. Immunocoprocytes and inflammatory cells indicative of certain gastrointestinal conditions and a noninvasive method for detecting colorectal cancer are set forth. Composition of transport and suspension media for isolation of colonocytes are detailed.
Abstract: A method for isolating viable, biologically substantially pure exfoliated fecal colonocytes at normal ambient temperature is described. Immunocoprocytes and inflammatory cells indicative of certain gastrointestinal conditions and a noninvasive method for detecting colorectal cancer are set forth. Composition of transport and suspension media for isolation of colonocytes are detailed.
Abstract: The invention discloses an isolated, biologically pure culture of a microorganism, Bacillus licheniformis, strain SB3086 for use as an environmentally desirable biofungicide. The invention also discloses a formulation comprising said bacterium and a method for controlling plant fungal diseases and infestation of Aspergillis niger utilizing said strain.
Abstract: A method for isolating viable, biologically substantially pure exfoliated fecal colonocytes at normal ambient temperature is described. Immunocoprocytes and inflammatory cells indicative of certain gastrointestinal conditions and a noninvasive method for detecting colorectal cancer are set forth. Composition of transport and suspension media for isolation of colonocytes are detailed.
Abstract: The present invention is directed to a new soluble double metal salt of group IA and IIA of (−) hydroxycitric acid of general formula I:
where X is IA group metal: Li or Na or K or Rb or Cs or Fr
where Y is IIA group metal: Be or Mg or Ca or Sr or Ba or Ra
where the concentration of X in the salt varies from 1.5-51.0%,
the concentration of Y in the salts varies from 2.0-50.9%,
the concentration of HCA in the salt varies from 31.0-93.0% depending on the nature of X and Y.
This invention more particularly relates to new soluble double metal salt of group IA and IIA of (−) hydroxycitric acid of general formula II.
Abstract: A method for isolating viable, biologically substantially pure exfoliated fecal colonocytes at normal ambient temperature is described. Immunocoprocytes and inflammatory cells indicative of certain gastrointestinal conditions and a noninvasive method for detecting colorectal cancer are set forth. Composition of transport and suspension media for isolation of colonocytes are detailed.
Abstract: The present invention defines a herbal composition for the treatment of chronic obstructive pulmonary disease, bronchitis and respiratory disorders and a process for preparing the same.
Abstract: A liquid and dry formulation suitable for use in enhancing plant growth which includes a plurality of Bacillus and Paenibacillus strains at least one of which function to produce phytohormones in a non-toxic form. The formulation also includes a phytohormone component and a phytohormone precursor to potentiate roots for colonization by the inoculated strains, as well as a low level blend of nutrients and micronutrients for optimal plant development.
Abstract: This invention relates to a process of preparing storage stable aqueous Azadirachtin containing Azadirachtin A to provide a predominant pesticidal composition which comprises the steps of diluting 50,000-100,000 ppm Azadirachtin with 25,000 to 50,000 Azadirachtin A weight/volume with ethanol water solvent in a ratio in the range 100-70:0-30 volume/volume to produce 2,000-40,000 ppm Azadirachtin containing 1,000-20,000 ppm of Azadirachtin A weight/volume. This is followed by emulsifying of the diluted Azadirachtin with non-ionic and non-toxic emulsifying agents in an amount ranging from 0.2 to 30% and neem oil 20-50% volume/volume. The pH of the emulsified diluted Azadirachtin is adjusted to 3.5 to 6.0 by adding an alkali solution. 1-2.5% of a sunscreen like p.aminobenzoic acid or its esters and 1-10% oleic acid volume/volume are added to create a micro-emulsion for stabilizing the composition with a good bio-efficacy.
Type:
Grant
Filed:
August 27, 1998
Date of Patent:
February 27, 2001
Assignee:
Dalmia Center for Research and Development